Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Bgi Genomics Co. Ltd.
Industry Sector: HealthTechnology
CEO: Li Jian Zhao
Number Of Employees: 3,752
Enterprise Value: $2,214,632,718
PE Ratio: -215.78
Exchange/Ticker 1: SZSE:300676
Exchange/Ticker 2: N/A
Latest Market Cap: $2,909,575,607
BioCentury | Mar 18, 2025
Data Byte
Wuxi stocks bounce back as Biosecure threat fades
Shares of Wuxi Apptec and Wuxi Biologics are closing in on pre-Biosecure levels
BioCentury | Dec 9, 2024
Politics, Policy & Law
Biosecure setback amid lawmakers’ push to reduce reliance on China
Defense bill places biotech under national security umbrella
BioCentury | Dec 5, 2024
Politics, Policy & Law
Biosecure compromise in the works, fate uncertain as deadline nears
Deal among lawmakers would give targeted companies chance to avoid sanctions
BioCentury | Nov 19, 2024
Politics, Policy & Law
As Congress considers Biosecure, report says WuXi companies low-risk
Rhodium Group report suggests Congress focus on economic rather than military threats from China biotech
BioCentury | Sep 27, 2024
Data Byte
CDMO shares rally on Biosecure’s slowing momentum, upbeat WuXi AppTec outlook
Stocks of China CDMOs, genomics companies rise as U.S. lawmakers head home with bill seeking to rein in select Chinese biotechs in limbo
BioCentury | Sep 20, 2024
Politics, Policy & Law
Another twist in the Biosecure drama leaves bill’s fate uncertain
Exclusion of Biosecure Act from Senate defense bill closes one door, but others remain open
BioCentury | Sep 11, 2024
Data Byte
Biosecure Act’s advance sinks shares of two WuXi entities
Passage of bill targeting Chinese CDMOs dents WuXi AppTec, WuXi Biologics stocks
BioCentury | Sep 10, 2024
Politics, Policy & Law
Biosecure passes House but Senate fate uncertain
Opposition from Democrats could lead Senate to modify or set aside the legislation
BioCentury | Jul 12, 2024
Politics, Policy & Law
Biosecure gains momentum, advancing in Senate, gaining backers
Biosecure Act introduced as amendment to Senate defense bill, endorsed by House Speaker Johnson
BioCentury | Jun 21, 2024
Politics, Policy & Law
Biosecure Act: The impact & what’s ahead — a BioCentury podcast
The broader implications of anti-China CDMO legislation
Items per page:
1 - 10 of 73